Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06696534Not ApplicableRecruiting

Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme

Role: lead

NCT06889844Recruiting

Observational Cross-reactivity Study for Colorectal Cancer Diagnosis

Role: lead

NCT06889883Recruiting

Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer

Role: lead

NCT06703632Not ApplicableRecruiting

Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection

Role: lead

NCT06738511Not ApplicableCompleted

Validation of a Molecular Signature for Early Detection of Colorectal Cancer

Role: lead

All 5 trials loaded